SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-16-006083
Filing Date
2016-06-27
Accepted
2016-06-27 16:02:58
Documents
2
Period of Report
2016-06-27
Effectiveness Date
2016-06-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A s103576_def14a.htm DEF 14A 735646
2 GRAPHIC tlogo.jpg GRAPHIC 13252
  Complete submission text file 0001615774-16-006083.txt   755127
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27072 | Film No.: 161733415
SIC: 2836 Biological Products, (No Diagnostic Substances)